EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Preoperative Inflammatory Blood Indices as Prognostic Markers in Oral Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis

Alexandros Louizakis iD, Dimitris Tatsis iD, Asterios Antoniou iD, Ioannis Astreidis iD, Effimia Stergiadou iD, Kalliopi Domvri, Konstantinos Paraskevopoulos iD, Simeon Metallidis, Konstantinos Vahtsevanos, Angeliki Cheva iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27177638 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Alexandros Louizakis und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Oral and Maxillofacial Surgery, School of Dentistry, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece. Hauptthemen laut MEDLINE: Mouth Neoplasms, Biomarkers, Tumor, Carcinoma, Squamous Cell, Inflammation. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oral squamous cell carcinoma (OSCC) prognosis remains limited by TNM staging alone. We conducted a systematic review and meta-analysis to evaluate preoperative neutrophil-to-lymphocyte (NLR), platelet-to-lymphocyte (PLR) and lymphocyte-to-monocyte (LMR) ratios as prognostic markers. We searched PubMed/MEDLINE, Scopus, Base, Google Scholar and ScienceDirect from inception to 30 May 2026. Eligible studies reported preoperative ratios and survival outcomes, namely, overall survival (OS), disease-specific survival (DSS) and disease-free survival (DFS), in surgically treated OSCC. Risk of bias was assessed with the QUIPS tool. Random-effects meta-analyses of multivariate hazard ratios (HRs) were primary; univariate data, heterogeneity, prediction intervals, sensitivity and subgroup analyses were also performed. Thirty-nine studies (12,153 patients; mostly East Asian retrospective cohorts) were included. Elevated NLR predicted worse overall survival (HR 1.51, 95% CI 1.32–1.73) and disease-specific survival (HR 2.00, 1.58–2.54). NLR also showed a significant association with DFS (HR = 1.47, 95% CI: 1.21–1.78), though the prediction interval crossed unity. PLR and LMR showed weaker, less consistent associations. Evidence was limited by predominant retrospective design, geographic concentration and variable cut-offs. Preoperative NLR is a reproducible, inexpensive prognostic biomarker that may complement TNM staging; standardized thresholds require prospective validation. The review was registered in PROSPERO; no specific funding was received.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mouth NeoplasmsBiomarkers, TumorCarcinoma, Squamous CellInflammationHumansPrognosisNeutrophilsLymphocytesBlood PlateletsDisease-Free Survival

Stichwörter der Autor:innen

hematologic parameterslymphocyte-to-monocyte rationeutrophil-to-lymphocyte ratiooral squamous cell carcinomaplatelet-to-lymphocyte ratioprognosisprognostic biomarkerssurvival

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Laboratory of Oral and Maxillofacial Surgery, School of Dentistry, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
  • Department of Oral and Maxillofacial Surgery, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
  • Department of Oral Medicine and Pathology, School of Dentistry, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
  • Department of Pathology, George Papanikolaou General Hospital of Thessaloniki, 54124 Thessaloniki, Greece.
  • Department of Internal Medicine, AHEPA University General Hospital, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece.
  • Department of Pathology, Faculty of Medicine, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.

ORCID-Profile: Alexandros Louizakis, Dimitris Tatsis, Asterios Antoniou, Ioannis Astreidis, Effimia Stergiadou, Konstantinos Paraskevopoulos, Angeliki Cheva

Zitieren

APA

Louizakis, A., Tatsis, D., Antoniou, A., Astreidis, I., Stergiadou, E., Domvri, K., Paraskevopoulos, K., Metallidis, S., Vahtsevanos, K., & Cheva, A. (2026). Preoperative Inflammatory Blood Indices as Prognostic Markers in Oral Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27177638

Vancouver

Louizakis A, Tatsis D, Antoniou A, Astreidis I, Stergiadou E, Domvri K, et al. Preoperative Inflammatory Blood Indices as Prognostic Markers in Oral Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27177638

BibTeX
@article{Louizakis2026,
  author = {Louizakis, Alexandros and Tatsis, Dimitris and Antoniou, Asterios and Astreidis, Ioannis and Stergiadou, Effimia and Domvri, Kalliopi and Paraskevopoulos, Konstantinos and Metallidis, Simeon and Vahtsevanos, Konstantinos and Cheva, Angeliki},
  title = {Preoperative Inflammatory Blood Indices as Prognostic Markers in Oral Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27177638}
}
Kostenlos starten →